Sanofi-Aventis and Bristol-Myers Squibb have cut a deal with a generic company that could keep a copycat version of their multibillion drug Plavix off the market until 2011. Sanofi-Aventis and Bristol ...

Patients who take a commonly prescribed drug have been warned of four potential side effects. According to the NHS, these ...

NEW YORK, June 19 (Reuters) - Canadian generic drugmaker Apotex Corp. said on Tuesday it would immediately appeal a U.S. court decision that found the patent on Plavix -- the widely-used blood clot ...

Shares in Bristol-Myers Squibb continued to decline on Friday as expectation grew that a generic form of its big-selling antithrombotic Plavix could be on the market in the USA later this year. Shares ...

Generic drug maker Apotex Inc. caught the market by surprise yesterday, launching a cheaper copy of the best-selling, blood thinner Plavix in the United States ahead of a likely patent infringement ...

WASHINGTON (AP) – Cheaper generic versions of blood thinner Plavix, the world’s second-best-selling medicine, have just been approved for sale. The Food and Drug Administration says it’s given seven ...

Plavix (clopidogrel) can cause side effects that range from mild to serious. More common side effects include bruising, bleeding, and itching. If side effects from Plavix become difficult to tolerate, ...

The cost of prescription medicines used by millions of people every day is about to plummet. The next 14 months will bring generic versions of seven of the world's 20 best-selling drugs, including the ...

In addition, there were no significant differences between the drug groups in the percent of patients who died or were hospitalized for any reason; had a stroke or transient ischemic attack ; or who ...

PARIS/LONDON, Oct 5 (Reuters) - French drugmaker Sanofi-Aventis is preparing to sell its own generic version of the blockbuster heart medicine Plavix in France, a company spokesman said on Monday.